Research-for-Cure Academy

Michael Besong

Nationality: Cameroonian
Institution: Biotechnology Center, University of Yaoundé
Country of work: Cameroon

What is your motivation for engaging in HIV cure and remission research?

As a young HIV researcher, I understand antiretroviral therapy has been very useful in reducing morbidity and mortality due to HIV, preventing mother-to-child transmission of HIV, and improving the health of People living with HIV. Despite these benefits, there still remain residual dysregulations and impairments in bodies’ systems due to the presence of the virus. There is therefore a need for a cure to completely eradicate the virus out of the tissues, and I desire to contribute in the efforts towards an HIV Cure.

What is your current area of research?

My current work with our research team is investigating the impact of early CMV infection on growth and neurodevelopment in HIV exposed uninfected infants (HEU), and the effect of in utero exposure of HIV/HAART on immune dysregulation and susceptibility to infections in the first year of life. We are also interested in understanding if an HIV cure will reverse the chronic inflammation and immune activation in the maternal environment and also the impact an HIV cure will have on health outcomes in HEU infants.